Safety of Continuing Chemotherapy in Overt Left Ventricular Dysfunction using Antibodies to Human Epidermal Growth Factor Receptor-2 Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • July 1, 2017 - June 30, 2019

total award amount

  • CAD 140000